Bordetella pertussis, the causative agent of whooping cough, has experienced a resurgence in the past 15 years, despite the existence of both whole-cell and acellular vaccines. Here, we performed whole genome sequencing analysis of 149 clinical strains, provided by the National Institute of Infectious Diseases (NIID), Japan, isolated in 1982–2014, after Japan became the first country to adopt acellular vaccines against B. pertussis. Additionally, we sequenced 39 strains provided by the Konan Kosei Hospital in Aichi prefecture, Japan, isolated in 2008–2013. The genome sequences afforded insight into B. pertussis genome variability and population dynamics in Japan, and revealed that the B. pertussis population in Japan was characterized by two major clades that divided more than 40 years ago. The pertactin gene was disrupted in about 20 % of the 149 NIID isolates, by either a deletion within the signal sequence (ΔSS) or the insertion of IS element IS481 (prn :: IS481). Phylogeny suggests that the parent clones for these isolates originated in Japan. Divergence dating traced the first generation of the pertactin-deficient mutants in Japan to around 1990, and indicated that strains containing the alternative pertactin allele prn2 may have appeared in Japan around 1974. Molecular clock data suggested that observed fluctuations in B. pertussis population size may have coincided with changes in vaccine usage in the country. The continuing failure to eradicate the disease warrants an exploration of novel vaccine compositions.
This is an open access article under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Kuno-SakaiH,
KimuraM.
Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization. Pediatrics International2004; 46:650–655 [View Article]
HaraM,
FukuokaM,
TashiroK,
OzakiI,
OhfujiS et al. Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan. BMC Infect Dis2015; 15:45 [View Article]
HoribaK,
NishimuraN,
GotohK,
KawaguchiM,
TakeuchiS et al. Clinical manifestations of children with microbiologically confirmed pertussis infection and antimicrobial susceptibility of isolated strains in a regional hospital in Japan, 2008–2012. Jpn J Infect Dis2014; 67:345–348 [View Article]
MooiFR,
van der MaasNAT,
de MelkerHE.
Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin. Epidemiol Infect2014; 142:685–694 [View Article]
KleinNP,
BartlettJ,
FiremanB,
AukesL,
BuckPO et al. Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine. Vaccine2017; 35:3395–3400 [View Article]
WarfelJM,
ZimmermanLI,
MerkelTJ.
Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA2014; 111:787–792 [View Article]
WarfelJM,
ZimmermanLI,
MerkelTJ.
Comparison of three whole-cell pertussis vaccines in the baboon model of pertussis. Clin Vaccine Immunol2016; 23:47–54 [View Article]
MooiFR,
HeQ,
van OirschotH,
MertsolaJ.
Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun1999; 67:3133–3134
BartMJ,
HarrisSR,
AdvaniA,
ArakawaY,
BotteroD et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio2014; 5:e01074 [View Article]
MooiFR,
van OirschotH,
HeuvelmanK,
van der HeideHG,
GaastraW et al. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun1998; 66:670–675
MooiFR,
van LooIHM,
van GentM,
HeQ,
BartMJ et al.Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis2009; 15:1206–1213 [View Article]
LoconsoleD,
de RobertisAL,
MoreaA,
MetalloA,
LopalcoPL et al. Resurgence of pertussis and emergence of the Ptxp3 toxin promoter allele in South Italy. Pediatr Infect Dis J2018; 37:1 [View Article][PubMed]
PawloskiLC,
QueenanAM,
CassidayPK,
LynchAS,
HarrisonMJ et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol2014; 21:119–125 [View Article]
KodamaA,
KamachiK,
HoriuchiY,
KondaT,
ArakawaY.
Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol2004; 42:5453–5457 [View Article]
SealeyKL,
HarrisSR,
FryNK,
HurstLD,
GorringeAR et al. Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving. J Infect Dis2015; 212:294–301 [View Article]
van GentM,
BartMJ,
van der HeideHGJ,
HeuvelmanKJ,
MooiFR.
Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One2012; 7:e46407 [View Article]
HegerleN,
ParisA-S,
BrunD,
DoreG,
NjamkepoE et al. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect2012; 18:E340E346 [View Article]
QueenanAM,
CassidayPK,
EvangelistaA.
Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med Overseas Ed2013; 368:583–584 [View Article]
BowdenKE,
WilliamsMM,
CassidayPK,
MiltonA,
PawloskiL et al. Molecular epidemiology of the pertussis epidemic in Washington State in 2012. J Clin Microbiol2014; 52:3549–3557 [View Article]
QuinlanT,
MusserKA,
CurrentiSA,
ZanskySM,
HalseTA.
Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004–2013. Mol Cell Probes2014; 28:138–140 [View Article]
ZeddemanA,
van GentM,
HeuvelmanCJ,
van der HeideHG,
BartMJ et al. Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill2014; 19:20881 [View Article][PubMed]
ClarkeM,
McintyrePB,
BlythCC,
WoodN,
OctaviaS et al. The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. J Infect2016; 72:171–178 [View Article]
SafarchiA,
OctaviaS,
WuSZ,
KaurS,
SintchenkoV et al. Genomic dissection of Australian Bordetella pertussis isolates from the 2008–2012 epidemic. J Infect2016; 72:468–477 [View Article]
XuY,
LiuB,
Gröndahl-Yli-HannuksilaK,
TanY,
FengL et al. Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis
. Sci Rep2015; 5:12888 [View Article]
WeigandMR,
PengY,
LoparevV,
BatraD,
BowdenKE et al. The history of Bordetella pertussis genome evolution includes structural rearrangement. J Bacteriol2017; 199:e00806-1616 [View Article]
BartMJ,
van der HeideHGJ,
ZeddemanA,
HeuvelmanK,
van GentM et al. Complete genome sequences of 11 Bordetella pertussis strains representing the pandemic ptxP3 lineage. Genome Announc2015; 3:e01394-15 [View Article]
BartMJ,
ZeddemanA,
van der HeideHGJ,
HeuvelmanK,
van GentM et al. Complete genome sequences of Bordetella pertussis isolates B1917 and B1920, representing two predominant global lineages. Genome Announc2014; 2:e01301-14 [View Article]
ParkJ,
ZhangY,
BuboltzAM,
ZhangX,
SchusterSC et al. Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens. BMC Genomics2012; 13:545 [View Article]
ParkJ,
ChenC,
HarvillET,
DudleyEG,
ZhangY.
Diversity of secretion systems associated with virulence characteristics of the classical bordetellae. Microbiology2015; 161:2328–2340 [View Article]
GatesI,
DuVallM,
JuH,
TondellaML,
PawloskiL et al. Development of a qualitative assay for screening of Bordetella pertussis isolates for pertussis toxin production. PLoS One2017; 12:e0175326 [View Article][PubMed]
LetunicI,
BorkP.
Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res2016; 44:W242–W245 [View Article]
ChanW-F,
MaharjanRP,
ReevesPR,
SintchenkoV,
GilbertGL et al. Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis. J Microbiol Methods2009; 77:326–329 [View Article]
TreangenTJ,
OndovBD,
KorenS,
PhillippyAM.
The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol2014; 15:524 [View Article]
TizolovaA,
GuisoN,
GuillotS.
Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome. Eur J Clin Microbiol Infect Dis2013; 32:89–96 [View Article][PubMed]
FryNK,
NealS,
HarrisonTG,
MillerE,
MatthewsR et al. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun2001; 69:5520–5528 [View Article]
duQ,
WangX,
LiuY,
LuanY,
ZhangJ et al. Direct molecular typing of Bordetella pertussis from nasopharyngeal specimens in China in 2012–2013. Eur J Clin Microbiol Infect Dis2016; 35:1211–1214 [View Article][PubMed]
GalitSR,
OtsukaN,
FuruseY,
AlmoniaDJ,
SombreroLT et al. Molecular epidemiology of Bordetella pertussis in the Philippines in 2012–2014. Int J Infect Dis2015; 35:24–26 [View Article][PubMed]
KomatsuE,
YamaguchiF,
AbeA,
WeissAA,
WatanabeM.
Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model. Clin Vaccine Immunol2010; 17:807–812 [View Article][PubMed]
WeberC,
Boursaux-EudeC,
CoralieG,
CaroV,
GuisoN.
Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol2001; 39:4396–4403 [View Article][PubMed]
BreakwellL,
KelsoP,
FinleyC,
SchoenfeldS,
GoodeB et al. Pertussis vaccine effectiveness in the setting of pertactin-deficient pertussis. Pediatrics2016; 137:5 [View Article]
ShuelM,
LefebvreB,
WhyteK,
HaydenK,
de SerresG et al. Antigenic and genetic characterization of Bordetella pertussis recovered from Quebec, Canada, 2002–2014: detection of a genetic shift. Can J Microbiol2016; 62:437–441 [View Article]
LittDJ,
NealSE,
FryNK.
Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol2009; 47:680–688 [View Article]
BarnesMG,
WeissAA.
BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infect Immun2001; 69:3067–3072 [View Article]
NobleGR,
BernierRH,
EsberEC,
HardegreeMC,
HinmanAR et al. Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. JAMA1987; 257:1351–1356
van LooIHM,
MooiFR.
Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology2002; 148:2011–2018 [View Article]
van LooIHM,
van der HeideHGJ,
NagelkerkeNJD,
VerhoefJ,
MooiFR.
Temporal trends in the population structure of Bordetella pertussis during 1949–1996 in a highly vaccinated population. J Infect Dis1999; 179:915–923 [View Article]
van TwillertI,
Bonačić MarinovićAA,
KuipersB,
van Gaans-van den BrinkJAM,
SandersEAM et al. Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis. Sci Rep2017; 7:40328 [View Article]
DorjiD,
MooiF,
YantornoO,
DeoraR,
GrahamRM et al.Bordetella pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Med Microbiol Immunol2018; 207: [View Article][PubMed]
GeurtsenJ,
FaeKC,
van den DobbelsteenGPJM.
Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis
. Expert Rev Vaccines2014; 13:1229–1240 [View Article]